Swine Health - PRRS
Targeted development of neutralizing monoclonal antibodies against PRRSV minor glycoproteins
February 26, 2021By Dr. Hiep Vu Ph.D.
Swine Health - PRRS
Development of a live-attenuated PRRSV vaccine capable of eliciting a broad spectrum of heterologous protection
February 26, 2021By Hiep Vu
PRRS modified live virus (MLV) vaccines have been licensed for clinical administration for over 20 years. The vaccines confer solid protection against homologous PRRSV strains. However, the extent...
Swine Health - PRRS
Recombinant porcine interferon to control PRRSV and select other viral pathogens
December 10, 2020By Bradley Blitvich
Swine Health - PRRS
Nanodisc-based mucosal DIVA vaccine for PRRS virus
September 30, 2020By Federico A. Zuckermann
Swine Health - PRRS
Evaluation of the intranasal route of MLV vaccination for large scale applications
May 2, 2020By Tanja Opriessnig
Swine Health - PRRS
Using genomic tools to link PRRSV quasispecies to disease severity in pigs infected with contemporary virulent isolates
March 4, 2020By Montse Torremorell
Swine Health - PRRS
Role of the viral ovarian domain protease in PRRSV pathogenesis
January 24, 2020By Dr. Kay S. Faaberg Ph.D.
Swine Health - PRRS
PRRSv detection over time in different age groups in breeding herds attempting to produce PRRSv-negative piglets at weaning: part 2: suckling pig population
December 20, 2019By Dr. Daniel Linhares DVM
Swine Health - PRRS
Characteristics of Unusually Virulent Contemporary PRRSV Isolates
November 26, 2019By Dr. Michael P. Murtaugh Ph.D.
Swine Health - PRRS
Genetic modifications in CD163 that confer complete resistance of pigs to infection with PRRSV
November 26, 2019By Dr. Raymond R. Rowland Ph.D.